MSK Flashcards

(370 cards)

1
Q

Description of septic arthritis?

A
  • Infection producing inflammation in native/prosthetic joint or more than one joint
  • Medical emergency and can destroy joint or develop sepsis <24 hour
  • Reaches via bloodstream, adjacent osteomyelitis or external skin puncture wounds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Epidemiology of septic arthritis?

A
  • Knee in >50% cases, followed by hip, shoulder, ankle and wrists
  • 1-2% incidence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk Factors of septic arthritis?

A
o	Age>80
o	Rheumatoid arthritis/Gout
o	DM
o	Immunosuppresion
o	Renal failure
o	Prosthetic joints/Recent surgery
o	IVDU
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Causative organisms of septic arthritis?

A
o	S.aureus (most common)
o	Streptococcus
o	N.gonorrhoea
o	TB
o	Salmonella
o	Coagulase neg staph – prosthetic joints
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Symptoms and signs of septic arthritis?

A

o Monoarticular
o Red, painful, swollen joint developing acutely
o Pain on active and passive movement and often held in position of most comfort (slightly flexed)
o May be fever, rigors, shaking, vomiting
- Signs may be less marked in elderly, IVDU, immunocompromised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Investigations needed in septic arthritis?

A
  • Bloods
    o FBC, ESR, CRP, blood cultures
  • Joint aspiration
    o Send for leukocyte count, Gram staining, microscopy and culture, ?AAFB
    o Infectious aspiration – yellow, turbid, purulent, >10000 cells, neutrophils, Gram stain and culture +ve
    o Normal aspiration – colourless/pale yellow, clear, 200-1000 cells, mononuclear cells, Gram stain and culture -ve
  • X-rays
    o Normal or soft tissue swelling with displacement of capsular fat planes and swelling of soft tissue
    o Later, bone destruction occurs
  • CT/MRI scan reserved for difficult cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Initial Management of septic arthritis? Orthopaedic management after referral?

A

o Analgesia
o IV Flucloxacillin for 2 weeks then oral switch for 4 weeks
 If penicillin allergic - Clindamycin
 If MRSA – Vancomycin
 If gonococcal – cefotaxime
 Empirical and start after aspiration
o Refer to Orthopaedic team for Joint irrigation/drainage, Analgesia, Splinting (In position of function, once infection under control then mobilisation will promote healing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of osteomyelitis/septic arthritis?

A
  • Flucloxacillin for 6 weeks
    o Consider adding fusidic acid or rifampicin for 1st 2 weeks
    o If penicillin allergic – clindamycin
    o If MRSA – vancomycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prognosis of septic arthritis?

A

o Mortality is 10-20%

o Around half regain baseline joint function after treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Description of giant cell arteritis?

A
  • Chronic immune-mediated vasculitis characterised by granulomatous inflammation in walls of medium and large arteries
  • Preferentially extracranial branches of carotid artery and branches of ophthalmic artery
  • GCA and polymyalgia rheumatica often occur together in 50%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Epidemiology of giant cell arteritis?

A
  • Incidence rare before 50 and peaks at 70
  • White people 7x more common
  • 3x more common in women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Symptoms of giant cell arteritis?

A
Headache
	Unilateral over temporal region
Temporal artery and scalp tenderness
	When combing hair
Jaw claudication
	Pain while eating
Amaurosis fugax
Sudden blindness in eye
Diplopia
Fever, fatigue, anorexia
Other – Neuropathy, morning stiffness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Signs of giant cell arteritis?

A

o Ischaemic disease on fundoscopy
o Temporal arteries – prominent, beaded, tender and pulseless
o Bruits may be heard over carotid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Suspect giant cell arteritis if..?

A
  • Suspect if >50 and:
    o New onset localised headache, unilateral in temporal area
    o Temporal artery – tender, thickened, nodular, red, pulseless
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When to refer people with suspected giant cell arteritis?

A
  • Refer all people for temporal artery biopsy
    o If visual impairment – same-day ophthalmology assessment
    o If no visual impairment – urgent rheumatology assessment (biopsy within 7 days)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What bloods tests to order in giant cell arteritis?

A

o ESR, CRP raised
o FBC – normochromic normocytic anaemia, elevated platelets
o LFT – mildly elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Initial drug treatment of giant cell arteritis?

A

Immediate Prednisolone 60mg/d PO
 Assess response over 1st 48 hours – if poor seek specialist advice
 If develop visual symptoms – seek same-day assessment for IV methylprednisolone
 Treatment reduced slowly and required for 1-2 years
Aspirin 75mg OD
Omeprazole 20mg OD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ongoing management of giant cell arteritis?

A

o If symptoms controlled – reduce dose of prednisolone slowly
 60mg until ESR/CRP normal, then reduce by 10mg every 2 weeks until 20mg daily, then reduce 2.5mg every 2-4 weeks until on 10mg daily, then 1mg evert 1-2 months

o Review a week after dose change and every 3 months for 1st year then 3-6 monthly
 Do ESR, CRP, BP and glucose

o Assess fracture risk and whether need bisphosphonates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Managing a relapse of giant cell arteritis?

A

o If visual disturbance – increase to 60mg prednisolone & same-day assessment with ophthalmologist
o If jaw claudication – increase to 60mg daily &seek specialist advice
o If headaches, or PMR – increase dose and seek specialist advice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Prognosis of giant cell arteritis?

A

o Relapses common – especially when steroid treatment reduced or withdrawn too quickly
o Exacerbations occur in 30-50% of people during first 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Complications of giant cell arteritis?

A
o	Visual Loss – total or partial
o	Aortic aneurysm, aortic dissection, large artery stenosis and aortic regurgitation
o	CVD
o	Peripheral neuropathy
o	Confusion and encephalopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Description of spinal cord compression?

A
  • Acute spinal cord compression is a neurosurgical emergency
  • Cancers leading to MSCC – breast, bronchus, prostate, myeloma/lymphoma but can occur with any tumour
  • Caused by tumour or metastases in vertebral body or paraspinal region pressing on spinal cord
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Epidemiology of spinal cord compression?

A
  • 2/3 in thoracic region

- Occurs in 20% of patients with spinal metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Aetiology of spinal cord compression?

A

o Metastases (breast, lung, prostate, thyroid, kidney)
o Cancer
o Trauma
o Cervical disc prolapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Symptoms of spinal cord compression?
o Back pain/nerve root pain  Either unilateral/bilateral, aggravated by movement, coughing or lying flat o Motor weakness – strength changes o Subjective sensory disturbances o Bladder/Bowel dysfunction generally occurs late
26
Signs of spinal cord compression?
o Weakness/Paraparesis/Paraplegia o Changes in sensation below level of compression o Hyperreflexia o Clonus and painless bladder distension o Can lead to paraparesis, paraplegia and incontinence
27
Red flags in spinal cord compression?
``` o Leg Weakness o Sensory Loss o Thoracic back pain o Constant pain o Urinary retention/incontinence o Saddle Anaesthesia & loss of anal tone ```
28
Management if suspected metastatic spinal cord compression?
o Contact MSCC coordinator urgently if:  Pain in thoracic or cervical spine, progressive lumbar spine, severe unremitting lower spinal pain, aggrevated by straining, local tenderness, nocturnal spinal pain o Contact MSCC coordinator immediately if signs of MSCC
29
Initial management of spinal cord compression?
Initial Management  Nurse flat with neutral spine  Offer graduated compression/anti-embolism stockings  Catheterise in bladder incontinent Medical  Urgent dexamethasone 16mg PO daily commenced at suspicion  PPI cover needed Imaging  Urgent Whole Spine MRI
30
Definitive management of spinal cord compression?
```  Surgery • Should have before they cannot walk • Postoperative radiotherapy  Radiotherapy • Urgent if surgery not suitable • Fractionated radiotherapy if epidural tumour without neurological involvement, pain or spinal instability ```
31
Prognosis of spinal cord compression?
- Outcomes correlate with level of function at the time of treatment - If treated within 24 hours, 57% will walk again - Complete paralysis, present for several days, is almost never reversible
32
What diseases have a positive rheumatoid factor?
```  Rheumatoid arthritis  Sjogrens syndrome  Felty’s syndrome  Infection  SLE, sclerosis ```
33
What diseases have a positive anti-CCP antibody?
 Rheumatoid arthritis
34
What diseases have a positive antinuclear antibody?
```  SLE  Autoimmune hepatitis  Sjogren’s syndrome  Systemic sclerosis  Rheumatoid arthritis ```
35
What diseases have a positive anti-double stranded DNA (dsDNA) & positive anti-Sm & positive anti-RNP??
 SLE
36
What diseases have a positive antihistone antibody?
 Drug-induced SLE
37
What diseases have a positive antiphospholipid antibody (anti-cardiolipin)?
 Antiphospholipid syndrome |  SLE
38
What diseases have a positive anti-Ro?
• SLE, Sjogren’s syndrome, systemic sclerosis
39
What diseases have a positive anti-La?
• Sjogren’s syndrome, SLE
40
What diseases have a positive anti-Jo-1 & anti-mi-2?
• Polymyositis, dermatomyositis
41
What diseases have a positive anti-Scl70?
• Diffuse systemic sclerosis
42
What diseases have a positive antimitochondrial antibodies (AMA)?
 Primary biliary cirrhosis  Autoimmune hepatitis  Idiopathic cirrhosis
43
What diseases have a positive anti-smooth muscle antibodies (SMA)?
 Autoimmune hepatitis |  Primary biliary cirrhosis
44
What diseases have a positive gastric parietal antibodies?
 Pernicious anaemia |  Atrophic gastritis
45
What diseases have a positive intrinsic factor antibodies?
 Pernicious anaemia
46
What diseases have a positive anti-tissue transglutaminase & anti-endomysial antibodies?
 Coeliac disease
47
What diseases have a positive thyroid peroxidase antibodies?
 Hashimoto’s thyroiditis |  Graves’ disease
48
What diseases have a positive islet cells Ab & glutamic acid decarboxylase?
 T1DM
49
What diseases have a positive anti-GBM?
 Goodpasture’s disease
50
What diseases have a positive antineutrophil cytoplasmic antibodies (ANCA) - cytoplasmic - specific for serine proteinase 3?
* Granulomatosis with polyangiitis (Wegeners) * Microscopic polyangiitis * Polyarteritis nodosa
51
What diseases have a positive antineutrophil cytoplasmic antibodies (ANCA) - perinuclear - specific for myeloperoxidase?
* Microscopic polyangiitis | * Churg-Strauss disease
52
What diseases also have a positive ANCA?
 ANCA also positive in Crohn’s, UC, sclerosing cholangitis, autoimmune hepatitis, Felty’s, SLE, RA, drugs (antithyroid, allopurinol, ciprofloxacin)
53
What diseases have a positive acetylcholine receptor antibodies?
 Myasthenia gravis
54
What diseases have a positive anti-voltage gated Ca-channel antibodies?
 Lambert Eaton Syndrome
55
Description of osteoarthritis?
Damage to synovial joints leads to repair and structural change o May occur through repeated excessive loading and stress of joint over time, or by injury Progressive loss of cartilage leads to exposed bone being sclerotic and increased vascularity Osteophytes form
56
Epidemiology of osteoarthritis?
- Commonest joint condition - Prevalence increases with age - Females 3>1 Males - Onset >50 years
57
Typical pattern in males and females of osteoarthritis?
- Females – hands and knees | - Males – hips
58
Risk factors of osteoarthritis?
``` o Familial o Age o Obesity o Joint damage or malalignment o Occupation/Sports ```
59
Symptoms in localised disease of osteoarthritis?
``` o Joint pain  Worse on movement  Relieved at rest  Worse at end of day  Joint gelling after 30 minutes of rest ``` o Crepitus, instability, loss of function
60
Symptoms in generalised disease of osteoarthritis?
o DIP, MCP, MTP and weight-bearing hips
61
Signs of osteoarthritis?
``` o Herbeden’s nodes (DIPs) o Bouchard Nodes (PIPs) o Joint tenderness, derangement o Decreased ROM o Mild synovitis o Muscle wasting o Baker’s cyst (OA/RA) ```
62
Diagnosis without imaging of osteoarthritis?
o If >45, has activity-related joint pain and NO morning stiffness or lasts <30 minutes
63
Investigations and their findings in osteoarthritis?
``` - CXR o Loss of joint space o Osteophytes o Subarticular sclerosis o Subchondral cysts - Raised CRP - Test for Rheumatoid if suspected ```
64
General Management of osteoarthritis?
o Leaflet/Arthritis UK website o Exercise to improve local muscle strength and improve aerobic fitness o Weight loss o Appropriate footwear, cold packs, walking aids o Local heat or ice can help
65
Analgesic management of osteoarthritis?
o Topical NSAIDs o If ineffective, short-term oral NSAID (+PPI) o Intraarticular steroid injection for moderate-to-severe pain Refer if conservative measures fail
66
When to refer to surgeon in osteoarthritis? What options are available?
o When?  Joint replacement if impacting on QoL and refractory to non-surgical treatment o Options?  Total joint replacement  Resurfacing  Fusion
67
Complications of osteoarthritis?
o Joint deformity o Functional impairment o Occupational impact o Falls
68
Description of osteoporosis? What are osteoporotic fractures?
- Low bone mass and structural deterioration of bone tissue – leads to increase in bone fragility and susceptibility to fracture - Osteoporotic fracture = fragility fracture occurring as consequence of osteoporosis
69
Definition of osteoporosis?
o Osteoporosis = Bone mineral density (BMD) of 2.5 SD below mean – measured by DEXA applied to femoral neck o Osteopenia = BMD between -1 and -2.5 on DEXA - It may be primary (age related) or secondary (to conditions or drugs)
70
Epidemiology of osteoporosis?
- Women mostly – due to decrease in oestrogen in menopause | - 1 in 3 women and 1 in 5 men will have fragility fracture
71
Risk Factors of osteoporosis - reduced bone mineral density?
```  DM, Hyperthyroidism, hyperparathyroidism  IBD, Coeliac, pancreatitis  CKD  Liver failure  COPD  Menopause  Immobility  BMI<18.5 ```
72
Risk factors of osteoporosis - does not reduce bone mineral density?
```  Age  Oral corticosteroids  Smoking  Alcohol >3 units daily  Previous fragility fractures  RA  Drugs – SSRIs, PPI, Carbamazepine ```
73
Symptoms of osteoporosis?
- Usually asymptomatic unless fragility fracture occurred
74
What are the at risk groups in osteoporosis?
Women >65, Men>75 ``` Over 50 if:  Previous osteoporotic fragility fracture  Use of corticosteroids  History of falls  BMI <18.5  Smoker  Alcohol >14 per week  Secondary cause ``` Under 50 if:  Use of corticosteroids  Untreated premature menopause  Previous fragility fracture Under 40 if:  >7.5mg prednisolone for >3 months  Previous or multiple fragility fracture Consider in:  SSRIs, carbamazepine, GnRH, PPIs, pioglitazone
75
Testing for at risk groups in osteoporosis?
o Online risk calculator (QFracture/FRAX) to predict 10 year risk  If high (>10%) – DEXA scan to measure BMD  If borderline but risk factors – DEXA scan to measure BMD
76
When to test without calculating risk in osteoporosis?
- Dual-energy X-ray absorptiometry (DEXA) scan to measure BMD without calculating risk if: o >50 with Hx of fragility fracture o <40 with major risk factor for fractures
77
Bloods performed in osteoporosis?
o Bone screen - Ca, PO4 and ALP usually normal
78
Management if DEXA >-2.5 or low risk of fractures in osteoporosis? When to reassess?
Lifestyle advice  Regular exercise – walking outdoors, strength training  Eat balanced diet  Stop smoking  Drink within recommended alcohol limits Reassess at minimum 2 years
79
Management if DEXA 2.5 or less in osteoporosis - drug treatment?
 Bisphosphonate (alendronate 10mg OD or 70mg once weekly; risedronate 5mg OD or 35mg once weekly) • Oral - if T-score <2.5 and QFRACTURE >1% • IV - if T-score <2.5 and QFRACTURE >10% and cannot take oral • Postmenopausal women and men >50 • Postmenopausal women alternative: Denosumab  If calcium adequate (>700mg/day) • 400 units of colecalciferol daily  If calcium inadequate: • 400 units of colecalciferol with 1000mg of calcium daily  HRT in women premature menopause (<40 years old)
80
Management if DEXA 2.5 or less in osteoporosis - lifestyle advice?
 Regular exercise – walking outdoors, strength training  Eat balanced diet  Stop smoking  Drink within recommended alcohol limits
81
Management if DEXA 2.5 or less in osteoporosis - follow up?
 Every 3-5 years • If high risk – continue alendronate for 10 years (7 for risedronate) • If not high risk – DEXA o Continue if 2.5 and reassess after 2 years
82
Description of rheumatoid arthritis?
- Chronic systemic inflammatory disease characterised by symmetrical, deforming, peripheral polyarthritis
83
Pathology of rheumatoid arthritis?
- Affects typically small joints of hands and feet but can be at any synovial joint - Synovial fluid inflammation leads to thickening of lining and infiltration by inflammatory cells - Synovium proliferates over cartilage leaving ‘pannus’ – destroys cartilage and bone
84
Epidemiology of rheumatoid arthritis?
- 1% of population - Females 2>1 Males - Incidence increases with age - Peak onset 50-60 years
85
Risk factors of rheumatoid arthritis?
``` o Women o Familial o Genetic  HLA-DR4/DR1 o Smoking ```
86
Symptoms of rheumatoid arthritis?
o Typical  Symmetrical swollen, painful and stiff small joints of hands and feet  Worse in morning (>30 minutes of stiffness) and after activity  Joint instability, subluxation and dislocation  Many joints can be affected o Less Common  Sudden onset, widespread arthritis  Recurring mono/polyarthritis o Systemic Illness  Fatigue, fever, weight loss, pericarditis, pleurisy
87
Signs of rheumatoid arthritis?
``` o Early (inflammation, no joint damage)  Swollen MCP, PIP, wrist, MTP joints ``` ``` o Later (joint damage, deformity)  Ulnar deviation of fingers  Dorsal wrist subluxation  Boutonnaire deformity  Swan-neck deformity  Z-deformity of thumbs  Rupture of extensor hand tendons  Similar foot deformities ```
88
Extra-articular signs of rheumatoid arthritis?
```  Nodules- elbows Lymphadenopathy  Vasculitis/Alveolitis/Bronchiolitis  Pleural/Pericardial Effusions  Reynauds/Carpal tunnel syndrome/Peripheral neuropathy  Splenomegaly  Episcleritis/Scleritis  Osteoporosis  Felty's Syndrome (Splenomegaly, RA, pancytopenia) ```
89
When should you refer person with suspected rheumatoid arthritis?
- All suspected should be referred to early arthritis clinic
90
Bloods performed in rheumatoid arthritis?
``` o FBC – anaemia o CRP, ESR increased o LFTs, U&Es o Rheumatoid Factor  Positive in 60-70% o Anti-Cyclic Citrullinated peptide antibodies (Anti-CCP)  Highly specific o Antinuclear antibodies  Positive in up to 30% of people ```
91
Imaging performed (if needed) in rheumatoid arthritis?
- X-Rays of hands and feet o Soft tissue swelling, osteopenia, decreased joint space o Later bony erosions, subluxation - Other options o USS/MRI o Aspiration  Sterile, high neutrophils
92
Diagnostic criteria of rheumatoid arthritis? When is diagnostic?
o People with >1 joint with definite swelling not explained by other disease o Add total scores ≥6/10 is diagnostic ``` A – Joint Involvement (swelling or tenderness +/- imaging evidence)  1 large joint = 0  2-10 large joints = 1  1-3 small joints = 2  4-10 small joints = 3  >10 joints (≥1 small) = 5 B – Serology  Negative RF & Anti-CCP = 0  Low +ve RF/Anti-CCP = 2  High +ve RF/Anti-CCP = 3 C – Acute phase reactants  Normal CRP/ESR = 0  Abnormal CRP or ESR = 1 D – Duration of symptoms  <6 weeks = 0  > 6 weeks = 1 ```
93
Management in primary care of rheumatoid arthritis?
 Referral needed if RA suspected • Urgently if small joint of hands and feet affected, >1 joint or delay of 3 months or more between symptom onset and seeking medical advice  Analgesia • Paracetamol with/without codeine • If not controlled: o NSAID/Coxib plus PPI
94
Secondary care investigations for diagnosis of rheumatoid arthritis?
* RF * Anti-CCP (if RF negative) * X-ray of hands and feet
95
Secondary care investigations following diagnosis of rheumatoid arthritis?
* Anti-CCP * X-ray in hands and feet * Functional ability (HAQ) for baseline
96
Management of flare up of rheumatoid arthritis?
Analgesia – NSAID, paracetamol, codeine o Offer PPI ``` Corticosteroid injection o IA (methylprednisolone acetate or triamcinolone acetonide) o IM (methylprednisolone acetate or triamcinolone acetonide) ``` Oral prednisolone
97
Lifestyle advice given in rheumatoid arthritis?
* Manage CVD and BP * Mediterranean diet * Stop smoking * Specialist Physiotherapy/OT * Alcohol stop * Pneumococcal and Influenza vaccine
98
Long-term management of rheumatoid arthritis - monitoring treatment response?
o CRP/ESR and disease activity using DAS28 score
99
Long-term management of rheumatoid arthritis - drug management?
1st step o DMARD monotherapy within 3 months onset (1st-line)  Methotrexate, leflunomide or sulfasalazine  Consider hydroxychloroquine as alternative 2nd step o Add another DMARD (oral methotrexate, leflunomide, sulfasalazine or hydroxychloroquine) when remission/low disease activity not achieved 3rd step o Add Biological Agents  Sarilumab + Methotrexate (if severe DAS28)  Others – adalimumab, etanerept, infliximab, certolizumab pegol, golimumab, tocilizumab, abatacept 4th Step o Methotrexate + Rituximab  If severe and no response to other DMARDs, including at least 1 TNF inhibitor
100
Long-term management of rheumatoid arthritis - surgical management?
* Refer - pain, function, deformity or synovitis progressing despite optimal non-surgical management * Refer – imminent or actual tendon rupture, nerve compression, stress fracture
101
Long-term management of rheumatoid arthritis - monitoring?
* 6 months after achieving remission or low disease activity * Annual review – assess HAQ * After 1 year of maintenance without steroids – consider stepping down dose of drug or stopping one DMARD
102
Description of polymyalgia rheumatica?
- Chronic, systemic inflammatory disease – characterised by aching and morning stiffness in the neck, shoulder and pelvic girdle - Usually >50 years old
103
Epidemiology of polymyalgia rheumatica?
- Most common inflammatory rheumatic condition in older people - Same demographics as GCA - Age >50
104
Risk factors of polymyalgia rheumatica?
o Older age - >65 o Females o Northern European o Infection (mycoplasma, chlamydia, parvovirus B19)
105
When to suspect polymyalgia rheumatica?
- Suspect in >50 with >2 week history of core symptoms: o Bilateral shoulder and/or pelvic girdle pain  Worse with movement  Interferes with sleep  May radiate to elbows and knees o Stiffness lasting >45 minutes  After waking or rest  May cause difficulty turning over in bed, rising from chair
106
Other features of polymyalgia rheumatica?
o Low grade fever, fatigue, anorexia and weight loss o Peripheral MSK signs:  Carpal tunnel syndrome, peripheral arthritis, swelling of limbs o NO WEAKNESS
107
Diagnosis of polymyalgia rheumatica?
o Core features o Excluding conditions that mimic PMR  GCA, active infection/cancer, arthritis, thyroid disease, statin-induced, myositis o Positive response to oral corticosteroids
108
Bloods to arrange in polymyalgia rheumatica?
o CRP raised o ESR raised (can be normal) ``` o Arrange in all patients:  TFT  FBC  LFT – raised ALP  Protein electrophoresis  CK levels normal  RF  Dipstick urinalysis ```
109
Tests to order if features of pathology in polymyalgia rheumatica?
 Urine Bence Jones proteins  ANA  Anti-CCP  CXR
110
Management of polymyalgia rheumatica if most likely diagnosis?
- If PMR most likely diagnosis: o Oral prednisolone 15mg OD  Follow up after 1 week to see response o After 3-4 weeks – ESR/CRP and consider reducing dose
111
When to make working diagnosis of polymyalgia rheumatica? And management from there?
- Make working diagnosis of PMR if >70% improvement within 1 week and normalised ESR/CRP in 4 weeks o If less response – increase dose to 20mg o If still no response – refer to rheumatology
112
How to reduce prednisolone when fully controlled symptoms in polymyalgia rheumatica?
``` o 15mg 3-4 weeks o Then 12.5mg for 3 weeks o Then 10mg for 4-6 weeks o Then reduce by 1mg every 4-8 weeks until stopped o Lasts 1-2 years ```
113
General advice in polymyalgia rheumatica?
o Provide blue steroid card | o Immediate medical attention if symptoms of GCA
114
Follow up of polymyalgia rheumatica?
- Follow Up o 1 week after dose change o Every 3 months – BP, glucose - Asses osteoporosis fracture risk
115
When to refer to rheumatologist with atypical PMR with no alternative diagnosis?
o <60 o Red flags – weight loss, night pain, neurological symptoms o Do not have core symptoms o Normal ESR/CRP or very high
116
When to refer polymyalgia rheumatica for specialist management?
o Relapsing when reducing dose o >2 years steroids o Repetitive flares o Lots of adverse effects
117
Complications of polymyalgia rheumatica?
o GCA and its complications - 15-20% | o Complications of long-term steroid use
118
Prognosis of polymyalgia rheumatica?
o Good – symptoms usually resolve within 24-72 hours o 1-2 years of treatment is required o Relapse common – responds to restarting or increasing dose of steroid
119
Description of gout?
- Raised uric acid level in blood and deposition of urate crystals in joints and tissues - Gout tends to attack joints in extremities as temperature in feet low enough to precipitate urate from plasma
120
Pathology of gout?
o Hyperuricaemia results from overproduction of uric acid and renal underexcretion o Urate derived from breakdown of purines (meat, peas, lentils, oats, mushrooms, spinach) o Impaired excretion (Kidney disease, hypertension, Increased PTH, diuretics/aspirin, hypothyroidism) o Increased production (Increased purines, PCV, Leukaemia, Carcinoma)
121
Epidemiology of gout?
- Most common inflammatory arthritis - Men 10x, prevalence increases with age - Prevalence increasing
122
Aetiology of gout?
``` o Cytotoxics o Hereditary o Increased dietary purines o Leukaemia o Diuretics o Alcohol o Associated CVD, HTN, DM, Renal failure ```
123
Symptoms of gout?
o Sudden onset, monoarticular pain, swelling and redness | o Most common MTP big toe, ankle, foot or hands
124
Investigations performed when gout suspected?
- Bloods o FBC, CRP, U&Es, cholesterol, glucose o May be done in primary care to find caused - Joint fluid microscopy and culture o Urate crystals – negatively bifringent o Rule out septic arthritis - X-ray o Soft-tissue swelling, then punched-out lesions in peri-articular bone - Serum Uric Acid o Done 4-6 weeks after acute attack to confirm increased uric acid
125
Management of acute attack of gout?
o General Advice Bed-rest Elevate and ice joint Keep joint in cool environment o Drug Treatment NSAIDs (Diclofenac 75mg bd or if CI colchicine 500mcg bd) Continue until 1-2 days after acute attack resolved Do not alter treatment if patient on long-term gout treatment Oral steroids could be used if NSAIDs CI (prednisolone 15mg od for 5 days) o Follow Up after 4-6 weeks Serum uric acid after 4-6 weeks (Aim <300micromol/L) Measure BP, HbA1c, U&E and lipids
126
Prevention advice of gout?
``` o Lose weight o Regular exercise o Stop smoking o Reduce alcohol intake o Stop diuretics o Diet – reduce cholesterol, avoid sugar-sweetened soft drinks avoid purine rich foods (meats and seafood) ```
127
Drug prevention in gout?
Allopurinol o after 1st attack of gout o Start at 100mg (50 if renal impairment) OD, increased in increments of 100mg every 4 weeks until SUA <360 (<300 if frequent flares or tophi) o Commence after acute attack when not in pain Colchicine cover with starting allopurinol  Alternative – febuxostat 80mg OD, up to 120mg OD
128
When to refer to rheumatologist in gout?
o Diagnosis uncertain or during pregnancy or <30 o Persistent symptoms on maximum anti-inflammatory medication o Intra-articular steroid injection o Person requires urate-lowering therapy but allopurinol and febuxostat CI or not tolerated o Complications present
129
Prognosis of gout?
o Self-limiting – usually resolve within 1-2 weeks | o Around half recur within a year
130
Complications of gout?
o Tophi occurs in 50% with untreated gout – may become inflamed and infected o Urinary stones common in people with gout o Risk factor for chronic kidney disease
131
Description, symptoms, investigations and management of pseudogout?
o Calcium pyrophosphate deposition in hyaline and fibrocartilage o Typically affects knees, wrists, hips of elderly with history of arthritic attacks o Associated with hyperparathyroidism, haemochromatosis, Wilson’s disease, hypothyroidism o X-rays show chondrocalcinosis in joint menisci, tendon insertion, ligament, bursa o Aspiration – weakly positively bifringent crystals on microscopy o Rx – NSAIDs and rest
132
Description of vasculitis?
- Inflammatory disorder of blood vessel walls, causing destruction (aneurysm/rupture) or stenosis - Can be primary (occurring on own) or secondary (SLE, RA, hepatitis B/C, HIV)
133
Classification of vasculitis - large vessel?
 Giant cell arteritis |  Takayasu’s arteritis
134
Classification of vasculitis - medium vessel?
 Polyarteritis Nodosa |  Kawasaki Disease
135
Classification of vasculitis - small vessel?
```  ANCA positive • P-ANCA – microscopic polyangiitis, glomerulonephritis, Churg-Strauss syndrome • C-ANCA – Wegener’s granulomatosis  ANCA negative • Henoch-Schonlein purpura • Goodpasture’s syndrome • Cryoglobulinaemia  Other Causes: • SLA, RA, IBD • Drugs – sulphonamides, Beta-lactams, quinolones, NSAIDs , OCP, thiazides • Neoplasm – hairy cell leukaemia ```
136
Symptoms of vasculitis - large vessel?
```  End-organ (TIA/CVA)  Hypertension  Aneurysms  Dissection  Visual changes, jaw claudication ```
137
Symptoms of vasculitis - medium vessel?
```  Ulcers  Digital infarcts  Nodules  Livedo reticularis  Papulo-necrotic lesions  Hypertension ```
138
Symptoms of vasculitis - small vessel?
```  Palpable purpura 1-3mm  Tiny papules  Spinter haemorrhages  Urticaria  Vesicles  Haematuria ```
139
Specific symptoms depending on organs affected in vasculitis?
o Systemic – fever, malaise, weight loss, arthralgia, myalgia o Skin – purpura, ulcers, livedo reticularis, splinter haemorrhages, digital gangrene o Eyes – episcleritis, slceritis, visual loss o ENT – epistaxis, nasal crusting, stridor o Pulmonary – SOB, haemoptysis o Cardiac – angina, MI, heart failure, pericarditis o GI – pain, malabsorption o Renal – hypertension, haematuria, proteinuria, casts, renal failure o Neuro – TIA/CVA, fits, chorea, psychosis, confusion, altered cognition o GU - orchitis
140
Investigations performed in vasculitis?
``` - Bloods o FBC, U&E, LFT o CRP/ESR o ANCA o RF o Anti-CCP - Urine dip, microscopy and culture - Biopsy - Echocardiogram and blood cultures if murmur ```
141
Management of vasculitis?
- Referral to rheumatologist - Specific Treatments o Large Vessel – Steroids (Azathioprine) + bisphosphonates o Medium/Small Vessels – Steroids and IV cyclophosphamide (Azathioprine) o ANCA positive – Mycophenolate mofetil
142
What is Wegener's granulomatosis?
- Granulomatosis with polyangiitis - Necrotising granulomatous inflammation and vasculitis of small and medium vessels (predilection for lungs, URT, kidneys)
143
Symptoms of Wegener's granulomatosis?
o Nasal obstruction, ulcers, epistaxis, saddle nose deformity o Glomerulonephritis - Proteinuria, haematuria o Cough, haemoptysis o Skin purpura, mononeuritis multiplex, arthritis, keratitis, scleritis, episcleritis
144
Tests performed in Wegener's granulomatosis?
o cANCA o Raised ESR/CRP o Urinalysis – proteinuria, haematuria o CXR – nodules and fluffy infiltrates
145
Management of Wegener's granulomatosis?
o Prednisolone and cyclophosphamide o Azathioprine and methotrexate (steroid sparing) o Co-trimoxazole prophylaxis against PCP
146
Description of Takayasu's arteritis?
- Systemic vasculitis affecting aorta and major branches - Granulomatous inflammation causes stenosis, thrombosis and aneurysm - Rare outside Japan, affects 20-40
147
Symptoms of Takayasu's arteritis?
- Symptoms o Dizziness, visual changes, weak arm pulses, fever, malaise - Complications o Aortic regurgitation, aortic aneurysm, dissection, stroke, IHD
148
Diagnossi of Takayasu's arteritis?
o ESR, CRP raised | o MRI
149
Management of Takayasu's arteritis?
o Prednisolone o Methotrexate or cyclophosphamide if refractory o Angioplasty +/- stenting
150
Description of Kawasaki Disease?
- Systemic vasculitis with coronary arteritis – coronary artery aneurysms - Commonest cause of acquired child heart disease
151
Diagnostic criteria of Kawasaki Disease?
o Fever for 5 days and 4 out of 5 of following:  Conjunctivitis without pus  Cervical lymphadenopathy  Extremity changes – swelling of hands/feet and desquamation  Rash  Lips- red, cracking or strawberry tongue
152
Investigations of Kawasaki Disease?
o Bloods – CRP and ESR raised | o ECG and echo to rule out CV complications
153
Management of Kawasaki Disease?
o High dose IV immunoglobuilin 2g/kg within 10 days o Corticosteroids - prednisolone -if IV-ImmunoGlobulin ineffective o Aspirin 30-50mg continued for atleast 6 weeks
154
Description of Henoch-Schonlein Purpura?
- Acute IgA mediated vasculitis causing medium sized artery inflammation - Occurs between 3-10, boys mostly - Aetiology – infection (group-A strept, mycoplasma, EBV, drugs and allergies
155
Symptoms of Henoch-Schonlein Purpura?
o Preceding URTI in 50-90% cases o Skin Rash Symmetrical, palpable purpura over buttocks, extensor surfaces, arms, legs and ankles Initially uticarial -> becoming maculopapular -> subsequently purpuric Recurs over several weeks o Arthralgia Knees and ankles mainly o Colicky Abdo Pain Intussusception (2/3%) o Renal Nephropathy 80% of cases have micro/macro-scopic haematuria or mild proteinuria Complete recovery is normal but if proteinuria is severe, nephritic syndrome o Scrotal Oedema
156
Investigations of Henoch-Schonlein Purpura?
o Mid-stream urine – protein and haematuria o BP o Bloods – FBC, ESR, U&E, IgA o Imaging – Renal US and biopsy
157
Management of Henoch-Schonlein Purpura?
o Most resolve in <2 months o Usually self-limiting, regular paracetamol and NSAIDs may help joint pain but caution in renal insufficiency o If severe, prednisolone may help resolve abdominal pain o May require admission to hospital for monitoring of abdominal and renal complications
158
Description of Goodpasture's syndrome?
- Acute glomerulonephritis + lung involvement (haemoptysis, diffuse pulmonary haemorrhage) - Caused by anti-GBM antibodies (bind to kidney basement membrane and alveolar)
159
Management of Goodpasture's syndrome?
- Tests – CXR, renal biopsy | - Management – prednisolone and plasmaphoresis
160
Description of low back pain?
- Pain in lumbosacral area of back, between buttocks and bottom of ribs - Specific causes – sciatica, vertebral fracture, intra-abdominal pathologies and rare, ankylosing spondylitis, cancer and infection - Non-specific when no specific cause and may be due to trauma or MSK injury
161
How common is low back pain?
- 60% people have low back pain in their life
162
Risk factors of low back pain?
o Obesity o Physical inactivity o Heavy lifting o Depression
163
Symptoms of non-specific back pain?
o Pain varies with posture and time, exacerbated by movement
164
Red flag symptoms needing investigation in low back pain?
o Cauda equina syndrome – bilateral neurological deficit of legs, urinary retention/incontinence, faecal incontinence, perianal sphincter loss, saddle anaesthesia o Cancer of spine - >50, gradual onset, unremitting pain, remains when supine and aching at night that disturbs sleep, spinal tenderness, unexplained weight loss, Hx of cancer o Spinal fracture due to trauma or osteoporosis – sudden onset, severe central spinal pain, relieved by lying down, history lf major trauma, deformity of spine, tenderness o Spinal infection – fever, TB, diabetes, IVDU, HIV
165
Management of low back pain - if red flag symptoms?
- If red flag symptoms – admit or refer urgently for assessment
166
Management of non-specific back pain?
o Risk stratification STarT Back to identify risk factors o Self-Management Advice  Exercises - leaflets  Local heat  Stay active and resume normal activities and work as soon as possible o Analgesia  NSAIDs (ibuprofen or naproxen)  Codeine 2nd line  If muscle spasm – give diazepam 2mg up to TDS for 5 days o Group exercise programmes o CBT if psychological element
167
Management of low back pain - if initial management not working for patient?
o Radiofrequency denervation if supplied by medial branch nerve o Spinal cord stimulation
168
Follow up in low back pain?
o If worsening or persist after 3-4 weeks, come back to GP
169
Prognosis of low back pain?
- Non-specific back pain resolves within 4 weeks usually | - May have episodes of recurrence
170
Description of prolapsed disc?
- Part of nucleus pulposus herniates through weakness in outer part of disc - Majority L4/5 or L5-S1
171
Pathology of prolapsed disc?
o Usually occur postero-laterally when annulus fibrosis is thin and not supported by longitudinal ligaments o Herniation will impinge on nerves below
172
Epidemiology of prolapsed disc?
- Degeneration of disc - Trauma - General wear and tear - Lifting heavy loads
173
Aetiology of prolapsed disc?
- Degeneration of disc - Trauma - General wear and tear - Lifting heavy loads
174
Symptoms of prolapsed disc?
- Sudden, onset, severe back pain – usually following strenuous exercise - Clearly related to position and aggravated by movement - Radiation depends on nerve impingement: o S1 – buttock to back of foot o L5 – Buttock to lateral leg and dorsal foot o L4 – Lateral aspect of thigh to medial calf - Typically, one sided but can be bilateral if large - Bowel & Bladder incontinence
175
Signs of Cauda Equina Syndrome?
- Bilateral root pain in legs - Saddle anaesthesia - Loss of anal tone PR - Bladder + Bowel incontinence
176
Imaging of prolapsed disc?
- X- rays often normal - Need good examination - MRI diagnostic and can identify for surgery
177
Management of prolapsed disc?
``` Symptomatic relief - NSAIDs, paracetamol, codeine, bed rest Steroid injection Physio & Exercise Surgery (if worsening, not settled in 6 weeks) ```
178
Description of sciatica?
- Sciatic nerve L4-S3 | - Symptoms arise from impingement of lumbosacral nerve roots and felt in sciatic dermatome
179
Epidemiology of sciatica?
- Around 15-40% of patients experience sciatica at some point during lifetime - Incidence related to age, peaking in 5th decade - Rarely seen before 20
180
Risk factors of sciatica?
- Strenuous physical activity - Whole body vibration - Smoking, obesity, occupational factors
181
Causes of sciatica?
- Slipped disc (90% of cases) - Spondylolisthesis – proximal vertebra moves forward relative to distal vertebra - Spinal stenosis o Narrowing of spinal canal – pain relived by forward flexion and worsened on extension - Infection and Cancer (rare)
182
Symptoms of sciatica?
- Affect hamstrings and all muscles below knee (foot drop), with loss of sensation below knee laterally - Unilateral leg pain radiating below the knee to the foot or toes - Low back pain – not too severe - Numbness, tingling (paresthesia) and muscle weakness in dermatome
183
Red flags in back pain of sciatica?
- Cauda equina syndrome - Spinal fracture o Sudden onset relieved by lying down o Hx of trauma, strenuous lifting, osteoporosis o Point tenderness over vertebral body - Cancer o >50, gradual onset of symptoms o Severe, unremitting pain – aching at night, unexplained weight loss - Infection (discitis, vertebral osteomyelitis, spinal epidural abscess) o Fever, TB, diabetes, Hx of IVDU, HIV
184
When to refer sciatica?
- Urgent referral if red flag suspicion
185
General advice in sciatica?
- Use STarT Back to identify risk factors - Self-management advice o Information – symptoms usually settle in 4-6 weeks o Local heat may help o Small firm cushion between knees while sleeping o Leaflets o Encourage active, normal daily activities
186
Analgesia in sciatica?
``` o NSAIDs (ibuprofen, naproxen) +/- paracetamol o Add amitriptyline, duloxetine, gabapentin, pregabalin o Benzodiazepines (diazepam 2mg TDS up to 5 days) for muscle spasm ```
187
Follow up of sciatica?
- Seek follow-up if worsening or not improving after 2-3 weeks
188
Management options in certain groups of patients for sciatica?
- Group exercise programme (biomechanical, aerobic) - Physiotherapist - CBT if they have psychosocial obstacles to recovery
189
Complications of sciatica?
- Permanent nerve damage with possible sensory deficits and motor weakness, such as foot drop - Anxiety, depression and psychosocial impact - Time off work, loss of employment
190
Prognosis of sciatica?
- Usually transient with improvements seen within weeks or a few months - Poorer prognosis seen in women, more severe sciatica - May have recurrence of symptoms
191
Definition of spondyloarthritis?
o Group of inflammatory rheumatologic conditions o Can be axial (affecting sacroiliac joints and spine) or peripheral (psoriatic arthritis, reactive arthritis, enteropathic spondyloarthritis)
192
Description of ankylosing spondylitis?
- Ankylosing Spondylitis (radiographic axial spondyloarthritis) o Inflammatory axial spondyloarthritis with sacroilitis on x-ray is characteristic
193
Epidemiology of ankylosing spondylitis?
- Prevalence 0.25-1% - 3x more common in men and present earlier than women - Present between 20-30
194
Aetiology of ankylosing spondylitis?
- Unknown aetiology | - 90% HLA B27 positive
195
Symptoms of ankylosing spondylitis?
- Gradual onset, recurrent low back pain and stiffness o Worse at night with spinal morning stiffness (>30 minutes) o Relieved by exercise - Pain radiates from sacroiliac joint to hips and buttocks - Loss of spinal movement due to new bone formation (SI ankylosis and syndesmophytes (bony growths in intervertebral joint ligaments) - Fatigue
196
Signs of ankylosing spondylitis?
- Kyphosis and neck hyperextension - Dactylitis (swelling of fingers and toes) - Arthritis - Enthesitis – inflammation of site of tendon/ligament insertion (costchondritis, plantar fasciitis, Achilles tendonitis) - Acute anterior uveitis
197
Blood tests & imaging to perform in patient suspected of ankylosing spondylitis?
- Bloods in primary care o ESR, CRP, FBC (normocytic anaemia) - Local guidelines on X-ray (sacroiliitis), MRI, USS o Sacroiliitis, sclerosis, erosions, total or partial ankylosis (fusion of joints)
198
Management if ankylosing spondylitis suspected?
o Refer to rheumatologist
199
Diagnostic criteria of ankylosing spondylitis?
o Modified New York Criteria | o ASAS classification criteria
200
Criteria of Modified New York Criteria in diagnosing ankylosing spondylitis?
o Modified New York Criteria  Diagnosed if • At least 1 clinical criteria + radiological criteria • All 3 clinical criteria without radiological evidence  Clinical • Low back pain - >3 months, improved by exercise but not relieved by rest • Limitation of lumbar spine movement in sagittal and frontal planes • Limitation of chest expansion  Radiological criteria • Sacroiliitis on XR
201
Criteria for ASAS classification criteria in diagnosing ankylosing spondylitis?
o ASAS classification criteria (for people with back pain for 3 months or more who were <45 at onset)  Sacroiliitis on imaging plus 1 or more feature of spondyloarthritis OR  HLA-B27 plus 2 or more features of spondyloarthritis • Features = inflammatory back pain, arthritis, enthesitis, uveitis, dactylitis, psoriasis, IBD, response to NSAIDs, FHx, high CRP
202
Imaging performed in ankylosing spondylitis?
o XR of sacroiliac joints
203
when can you diagnose ankylosing spondylitis?
XR shows sacroiliitis with New York criteria bilateral grade 2-4 or unilateral 3-4
204
Imaging if XR does not show sacroilitis but high NY score?
Unenhanced MRI
205
General advice in suspected ankylosing spondylitis?
o Chronic condition and no cure – need referral for confirmation o Exercise – maintain posture and mobility o If chest wall restriction – influenza and pneumococcal vaccine
206
Anaglesia in suspected ankylosing spondylitis?
o NSAIDs with PPI o Add paracetamol and codeine if NSAIDs CI o Corticosteroid injection for sacroiliitis/enthesitis
207
When to refer to rheumatologist in ankylosing spondylitis?
- Referral to rheumatologist if low back pain starting before 45 and lasting >3 months, plus 4 or more of the following: o Low back pain starting before 35 o Symptoms wake during second half of night o Buttock pain o Improvement when moving o Improvement within 48 hours of NSAIDs o 1st degree relative with spondyloarthritis o Current or past arthritis o Current or past enthesitis o Current or past psoriasis - If 3 are present – perform HLA-B27 test – if positive, refer to rheumatologist
208
Management of confirmed ankylosing spondylitis in primary care?
o Analgesia  NSAIDs with PPI  Add paracetamol and codeine if NSAIDs CI o Flare Management  Referral to secondary care – if recurrent flare ups, taking DMARDs, or comorbidities o 2-yearly osteoporosis DEXA scan o Manage modifiable risk factors  CVD, hypertension, lipid modification, obesity, smoking cessation o Referral  Ophthalmology if anterior uveitis suspected  Rheumatology if symptoms not controlled
209
Management of confirmed ankylosing spondylitis in secondary care - non-pharmacological?
- Specialist physiotherapy o Stretching, strengthening, postural exercises, deep breathing, range of motions - Consider hydrotherapy
210
Management of confirmed ankylosing spondylitis in secondary care - pharmacological?
- NSAIDs (at lowest effective dose) + PPI o If taken for 2-4 weeks and not adequate – switch NSAIDs - Biological DMARDs (assess after 12 weeks) o TNF-alpha inhibitors (adalimumab, etanercept, golimumab, infliximab) – severe and not responding to NSAIDs o Secukinumab – if not responded to NSAIDs or TNF-alpha inhibitors
211
Management of confirmed ankylosing spondylitis in secondary care - surgical?
o Refer when spinal deformity significantly affecting ADLs and severe or progressive despite optimal treatment
212
Managing flare ups of ankylosing spondylitis?
o Flare management plan with access to care, self-care advice, pain management and changes to medications
213
Prognosis of ankylosing spondylitis?
- 70-90% of those affected remain fully independent or minimally disabled long term - Spinal deformities may occur usually after 10 years - Worse prognosis in ESR >30, onset <16 and early hip involvement
214
COmplications of ankylosing spondylitis?
- Aortic regurgitation - Anterior uveitis - AV node block - Achilles’ tendon rupture - Spinal fractures - Fixed and flexed posture - Osteoporosis - Cauda equina syndrome
215
Definition of reactive arthritis?
- Seronegative spondyloarthritis, typically affecting lower limbs 1-4 weeks after urethritis (chlamydia ureaplasma) or dysentery (Campylobacter, salmonella, shigella, Yersinia)
216
What is Reiter's syndrome?
- Reiter’s syndrome – triad of urethritis, arthritis and conjunctivitis
217
Epidemiology of reactive arthritis?
- Young white adults | - Associated with HLA-B27
218
Risk factors of reactive arthritis?
- Post-venereal – Chlamydia, HIV | - Post-enteric – Campylobacter, Salmonella, Shigella
219
Symptoms of reactive arthritis?
- Symptoms 2-4 weeks after GU or GI infection o Acute malaise, fatigue and fever o Asymmetrical lower limb oligoarthritis o Low back pain o Enthesitis o May be iritis, keratoderma blenorrhagica (brown, raised plaques on soles and palms), circinate balanitis (painless penile ulceration), mouth ulcers
220
Investigations of reactive arthritis?
- Bloods o Raised ESR/CRP o FBC – normocytic, normochromic anaemia, mild leucocytosis and thrombocytosis o HLA-B27 positive - Joint aspiration to rule out septic arthritis o High WBC count (polymorphonuclear leukocytes) - Culture of stools, throat and urogenital tract to identify causative organism
221
Management of reactive arthritis?
- Immobilise affected joints - NSAIDs - Prednisolone – oral/intra-articular/topical - If symptoms >6 months – DMARD - sulfasalazine or methotrexate
222
Prognosis of reactive arthritis?
o Usually self-limiting with resolution in 3-12 months, may persist
223
Complications of reactive arthritis?
o Osteoarthritis | o Iritis/Uveitis
224
Description of polyarteritis nodosa?
Necrotising vasculitis causing aneurysms and thrombosis of medium-sized arteries, leading to infarction in organs (renal) with systemic symptoms
225
Epidemiology of polyarteritis nodosa?
Women 2x
226
Associated conditions of polyarteritis nodosa?
Hep B
227
Symptoms of polyarteritis nodosa?
Systemic features - fever, weight loss, headache, myalgia Neuro - mononeuritis multiplex Skin - livedo reticularis rash and punched out ulcers Renal - ischaemia Cardiac, GU and GI involvementt
228
Tests of polyarteritis nodosa?
Bloods - raised WCC, mild eosinophilia, anaemia, high Hep B surface antigien positive 30% ESR/CRP ANCA negative Renal/abdominal angiography - diagnostic of multiple aneurysms
229
Management of polyarteritis nodosa?
Control BP | Steroids and azathioprine/cyclophosphamide
230
Definition of Churg-Strauss Syndrome?
ANCA positive vasculitis affecting small arteries Triad of adult-onset asthma, eosinophilia and vasculitis affecting lungs (pulmonary infiltrates), skin, nerves (mononeuritis multiplex) and heart
231
Symptoms of Churg-Strauss Syndrome?
Systemic - fever, joint pain, muscle pain, weight loss, chest pain Pulmonary - asthma, pneumonitis URTI - sinusitis, rhinitis Heart - HF, myocarditis, MI Skin - purpura, skin nodules, livedo reticularis Renal - CKD, hypertension, glomerulonephritis Nerves - mononeuritis multiplex
232
Investigations of Churg-Strauss Syndrome?
ANCA - pANCA positive in 30% FBC - eosinophilia, high ESR/CRP U&E - high creatinine CXR - pulmonary opacities
233
Management of Churg-Strauss Syndrome?
Steroids Cyclophosphamide if severe Rituximab if refractory disease
234
Definition of Microscopic polyangiitis?
Necrotizing vasculitis affecting small and medium sized vessels
235
Symptoms of Microscopic polyangiitis?
Rapidly progressing glomerulonephritis | Pulmonary haemorrhage
236
Investigations of Microscopic polyangiitis?
pANCA positive
237
Management of Microscopic polyangiitis?
Control BP | Steroids and azathioprine/cyclophosphamide
238
Definition of Behcet's disease?
Systemic inflammatory disease with recurrent oral ulcers, associated with HLA-B5
239
Epidemiology of Behcet's disease?
Most common along old Silk Road - Mediterranean to China Age 20-30
240
Symptoms of Behcet's disease?
Recurrent oral and genital ulceration Uveitis Skin (erythema nodosum, papulopustular lesions) Arthritis (non-erosive large joint oligoarthritis) Vasculitis Pathergy - exaggerated skin injury occuring after minor trauma Myo/pericarditis Colitis CNS - memory impairment, pyramidal signs
241
Diagnosis of Behcet's disease?
Clinical Pathergy test - needle prick leads to papule formation within 48 hours
242
Management of Behcet's disease?
Topical steroids for oral/genital ulcers Azathioprine/Cyclophosphamide for systemic disease Infliximab
243
Definition of Buerger's Disease?
Called thromboangiitis obliterans Non-atherosclerotic smoking-related inflammation and thrombosis of veins and middle-sized arteries causing thrombophlebitis and ischaemia (ulcers and gangrene) Men aged 20-45
244
Aetiology of Buerger's Disease?
Unknown but smoking leads to development/progression of disease
245
Symptoms of Buerger's Disease?
Claudications in feet/hands or pain at rest Begins in extremities and may radiate centrally Discolouration of limbs, symptoms worsen with cold or stress, numbness or tingling, Raynauds' phenomenon, skin ulcers, digital gangrene
246
Investigations of Buerger's Disease?
To rule out other vasculitis - FBC, LFTs, U&E, glucose, ESR, CRP, autoantibodies Imaging - angiography - corkscrew appearance of arteries
247
Management of Buerger's Disease?
Stop smoking!! Avoid cold, sitting or standing in one position for long Avoid tight clothing Aspirin/Iloprost
248
Description of seronegative arthritis?
- Group of conditions that present with inflammatory arthritis without a positive RF - Include Ankylosing spondylitis, Reiter’s syndrome, psoriatic arthritis, Behcet’s disease, JIA
249
Risk factors of seronegative arthritis?
o HLAB27 | o FHx
250
Mean onset and symptoms of seronegative arthritis?
``` - Mean onset 20-40 o Back pain o Sacroilitis o Peripheral arthritis o Enthesitis o Dactylitis o Non-gonococcal urethritis o Psoriasis o Anterior Uveitis o IBD ```
251
What is psoriatic arthritis?
o 35-45, any joints o Psoriasis, enthesitis, dactylitis o Occasional uveitis, aortic regurgitation
252
What is enteropathic arthritis?
o Any age o Asymmetrical lower extremities and symmetrical sacriliitis o Erythema nodosum, pyoderma gangrenosum o Aortic regurgitation
253
Investigations in seronegative arthritis?
- Bloods o ESR and CRP raised o Urate, RF, ANA normal - X-ray
254
Management of seronegative arthritis?
- Treat the type of spondylopathy - Exercise, physiotherapy - NSAIDs - DMARDs - Surgery – joint replacements
255
Physiology of vitamin D?
- Vitamin D is fat soluable vitamin that regulates calcium and phosphate homeostasis - Promotes absorption of calcium and phosphorus from bowel to mineralise newly formed osteoid bone tissue
256
Forms of vitamin D?
o Vitamin D3 (cholecalciferol) – synthesised from 7-dehydrocholesterol in skin by UVB radiation (sunlight) o Both D3 and D2 (ergocalciferol) are obtained from foods  Cod liver oil, oily fish and fortified cereals/spreads o D2 and D3 are inactive – converted to 25-hydroxyvitamin D in liver and then to 1, 25(OH)2D in kidneys
257
Regulation of vitamin D?
o Production regulated by PTH on kidneys
258
Definition of osteomalacia and Ricket's?
- Osteomalacia – normal bone amount but mineral content low, occurs after fusion of epiphysis - Rickets = if this process occurs during period of growth
259
Causes of osteomalacia?
o Insufficient sunlight exposure  Depends on latitude, season and habit of dressing  Age  Darker skin need more sunlight o Inadequate dietary intake o Intestinal malabsorption – coeliac, CF, Crohn’s o Obesity o Liver failure o CKD o Drugs – antiepileptics, corticosteroids, rifampicin, HAART
260
Risk factors of osteomalacia?
``` o Muslim women o Housebound patients o Dark skin (African, Afro-Caribbean, Asian) o Vegans o Pregnancy o >65 o Obese o FHx ```
261
Symptoms of Ricket's?
o Growth retardation o Hypotonia o Apathy o Once walking: knock knee, bow legs, rachitic rosary o Painful wrist swelling o Craniotabes (skull softening with frontal bossing o Delayed tooth eruption
262
Symptoms of osteomalacia?
o Bone pain – lower back, pelvis o Fractures (esp femoral neck) o Muscles aches o Proximal myopathy (waddling gait)
263
Investigations in child with suspected Ricket's?
``` o XR of long bone – cupping, splaying, fraying of metaphysis (champagne glass wrist) o Bone profile  Vitamin D if low calcium o U&E o LFT o TFT o PTH o FBC, ferritin o RA o CRP/ESR ```
264
Investigations must be done in osteomalacia?
o Test serum 25(OH)D levels if present with symptoms  Diagnosis if <25nmol/L  25-50 may be inadequate for some people
265
Investigations considered if underlying cause suspected in osteomalacia?
```  Bone profile  U&E  LFT  TFT  PTH  FBC, ferritin  RA  CRP/ESR ```
266
Prevention management of osteomalacia?
o Take daily 400IU (10mcg) supplement daily throughout year  If pregnant – can get free Healthy Start vitamins (has vitamin D, 400mcg folic acid and 70mg VitC)  If <1 years old – 340-400IU of vitamin D o Advise to intake 700mg of calcium a day  If unable – combined calcium supplementation (Calcichew D3) • Check Ca levels 1 months after  If child, recommended levels are different o Lifestyle advice  Sun exposure – safely  Diet – supplements, cod liver oil, oily fish, egg yolk, meat
267
Management of osteomalacia - who to treat?
 Serum 25(OH)D <25  Serum 25(OH)D 25-50 if: • Fragility fracture, osteoporosis, on antiresorptive drug treatment, symptoms, raised PTH, CKD, coeliac, Crohn’s
268
Management of osteomalacia - how to treat?
 Refer if cancer, Crohn’s to specialist Drug treatment  Vitamin D2 – for strict vegans (from plant sources)  Vitamin D3 (cholecalciferol) for everyone else • Loading dose of 300000 IU (50,000 IU once a week for 6 weeks) then daily 800IU maintenance
269
Management of osteomalacia - follow up?
 1 month of high-dose Vitamin D treatment • Serum calcium levels  3-6 months of high-dose Vitamin D treatment • Serum 25(OH)D levels: o IF <50 – refer to secondary care o IF >50 and no symptoms of hypercalcaemia – maintenance dose of 800IU daily
270
Management of child with Ricket's?
o Refer is underlying cause o Refer to paediatrician if symptoms of Ricket’s o Drug Treatment  Age 1-6 months – 3,000 IU daily for 8-12 weeks  Age 6 months-12 years – 6,000IU daily for 8-12 weeks  Age 12-18 years – 10,000IU daily for 8-12 weeks
271
Prognosis of osteomalacia?
o Correct management – restores levels and reduces risks
272
Complications of osteomalacia?
``` o Hypocalcaemia o 20 hyperparathyroidism o Bone loss o Muscle weakness o Fragility fractures ```
273
Description of Paget's disease of the bone?
- Also called osteitis deformans - Increased bone turnover, increased osteoblasts and osteoclasts which results in: o Remodelling o Bone Enlargement o Deformity o Weakness
274
Epidemiology of Paget's disease of the bone?
- Incidence rises with age | - Commoner in temperate climates = England, USA
275
Risk factors of Paget's disease of the bone?
- Risk Factors - FHx - Paramyxoviruses - Male
276
Symptoms of Paget's disease of the bone?
- Aymptomatic 70% - Deep, boring pain - Bony deformity and enlargement – typically pelvis, lumbar spine, skull, femur and tibia (classical bowed sabre tibia)
277
X-ray findings of Paget's disease of the bone - Skull?
o Enlargement of bone o Patchy cortical thickening with sclerosis, osteolysis and deformity (osteoporosis circumscripta of skull)  Osteoporosis circumscripta – large, well-defined lytic lesions  Cotton wool appearance – mixed lytic and sclerotic lesions  Tam o-shanter sign – frontal bone enlargement
278
X-ray findings of Paget's disease of the bone - spine?
 Picture frame sign – cortical thickening and sclerosis encasing margins
279
X-ray findings of Paget's disease of the bone - long bone?
 Blade of grass/candle flame – advancing tip of V-shaped osteolysis to diaphysis
280
Other tests to perform in Paget's disease of the bone?
- Bone scintigraphy o Hot spots of bone - Bloods o Ca and PO4 normal o ALP markedly raised
281
Management of Paget's disease of the bone?
- Analgesia – NSAIDs + paracetamol - Bisphosphonates o Salmon Calcitonin 2nd line - Monitor Ca & Vitmain D levels - Surgery – deformity, osteoarthritis, nerve compression
282
Complications of Paget's disease of the bone?
``` o Pathological fractures o Osteoarthritis o High Calcium o Nerve compression o Osteosarcoma ```
283
Types of bone tumours - benign?
```  Osteoid osteoma  Chondroma, osteochondroma  Fibroma  Haemangioma  Giant cell tumour ```
284
Types of bone tumours - malignant?
```  Osteosarcoma  Chondrosarcoma  Fibrosarcoma  Ewing’s sarcoma, myeloma  Angiosarcoma ```
285
Description and management of osteoid osteoma?
o Usually <1cm in diameter and surrounded by dense osteoid o Young adults o Most common sites – tibia, femur, vertebrae o Present with pain, worse at night, and relieved by NSAIDs o X-ray – radiolucency surrounded by dense bone o Management – local excision
286
Description and management of osteochondroma?
o Sessile or pedunculated lesions arising from cortex of long bone adjacent to epiphyseal plate o Often present in adolescence as cartilaginous overgrowth at epiphyseal plate o Symptoms – painless lump, joint pain o Management – excision
287
Description and management of chondroma?
o Appears in tubular bones of hands and feet o X-ray – well-defined osteopenic area in medulla o Management – excision and bone graft
288
Description and management of giant cell tumour?
o Aggressive, locally recurrent tumour with low metastatic potential o Sub-articular cancellous region of lone bone – mostly in closed epiphyses around knee and distal radius o Symptoms – 20-40 females o X-ray – asymmetric rarefied area at end of long bone o Management – wide excision and joint replacement, amputation if malignant or recurrent
289
Description and management of chondroblastoma?
o Rare, in epiphysis of long bones o Symptoms – joint pain, muscle atrophy, tenderness o Management – curettage and bone grafting
290
Description and management of osteoblastoma?
o Locally destructive progressive lesion found in vertebrae o Presents with dull aching pain o Needs biopsy to exclude malignancy o Management – curettage/bone graft
291
Description and management of osteosarcoma?
o Most common bone malignancy in children o Occurs in metaphyses of long bone, around knee or proximal humerus o Symptoms – painless mass, destroys bone and rapidly metastasises to lung o X-ray – bone destruction and formation, soft-tissue calcification produces ‘sun-burst’ appearance o Management – Surgical excision and mifamurtide and chemo
292
Description, symptoms, investigations, staging and management of Ewing's sarcoma?
Common in white Caucasian <25, usually males Symptoms – mass or swelling in long bones of arms, legs, pelvis, chest, pain in area, redness, anorexia, malaise, weight loss, paralysis, numbness, tingling if nerve affected Investigations  X-ray – Bone destruction with overlying onion-skin layers of periosteal bone formation  Biopsy needed for diagnosis  FBC and LDH prognostic markers  CT/MRI Management  Chemotherapy (Vincristine, ifosfamide, doxorubicin, etoposide)  Radiotherapy  Surgery to remove tumour (limb saving or amputation)
293
Symptoms of bone tumours?
- Pain, swelling and localised tenderness | - Rapid growth and erythema suggest malignancy
294
Referral from primary care if suspected bone sarcoma?
2-week (48 hours if child) X-ray if unexplained bone swelling or pain, then 2-week (48 hours if child) appointment if X-ray suggest possibility
295
Referral from primary care if suspected soft tissue sarcoma?
urgent US (48 hours if child) if unexplained lump increasing in size, then 2-week (48 hours if child) appointment if US suggestive of soft tissue sarcoma
296
Description of SLE?
- Multisystem autoimmune disease where autoantibodies are made against a variety of autoantigens (e.g. ANA) - Polyclonal B-cell secretion of autoantibodies causing tissue damage via immune complexes, deposition and complement activation
297
Epidemiology of SLE?
- Women 9x, typically of child-bearing age | - More common in Afro-Caribbean, Asians
298
Risk factors of SLE?
``` o HLA- DR3/2 o EBV o Drugs  Isoniazid, hydralazine, procainamide, quinidine, chlorpromazine, minocycline, phenytoin  Disease remits if drugs stopped ```
299
Symptoms of SLE?
- Remitting and relapsing pattern o Non-Specific - Malaise, fatigue, myalgia, fever, lymphadenopathy, weight loss, alopecia, non-infective endocarditis, Raynaud’s, migraine, stroke
300
Criteria for diagnosis of SLE?
``` o If 4 or more/11 criteria: Malar Rash (butterfly rash) - Fixed, erythema, flat or raised over malar eminences sparing nasolabial folds ``` Discoid Rash - Erythematous raised patches with keratotic scales and follicular plugging +/- atrophic scarring - Affects ears, cheeks, scalp, forehead Photosensitivity - On exposed skin, may also cause disease to flare Oral Ulcers Serositis - Pleuritis OR Pericarditis Non-Erosive Arthritis - Involving 2 or more peripheral joints, reversible deforming arthropathy may occur due to capsular laxity (Jaccoud’s arthropathy) - Joint and muscle pain – early morning stiffness - Non-erosive Renal Disorder - Persistent proteinuria OR Cellular casts CNS disorders - Seizures OR Psychosis Haematological disorders - Haemolytic Anaemias with reticulocytosis OR Leukopenia OR lymphopenia OR thrombocytopenia Immunological disorders - Anti-dsDNA OR anti-Sm OR antiphospholipid antibody positive Antinuclear antibody (ANA)
301
Screening tests used in SLE?
o FBC o ESR o Plasma viscosity o ANA
302
Further tests performed in SLE?
``` Antibodies  ANA  Anti-dsDNA  Anti-Sm  Anti-SSA/SSB  Antiphospholipid syndrome Complement – low C3 and C4 ESR raised BP Urinalysis and urine M, C & S FBC (normochromic, normocytic anaemia), U&E, LFT, CRP ```
303
Management of SLE - flare ups?
o IV cyclophosphamide + high-dose prednisolone
304
Management of SLE - maintenance - general measures?
 Smoking Cessation  Sun protection  Exercise
305
Management of SLE - maintenance - joint symptoms?
 NSAIDs and hydroxychloroquine  Low-dose prednisolone  Steroid sparing - Azathioprine, methotrexate and mycophenolate  Cyclophosphamide reserved for life-threatening disease
306
Management of SLE - maintenance - mucocutaneous disease?
 Sun protection  Chlorhexadine, basic oral hygiene and dental appointments  Artificial saliva preparations for dry mouth  Hypromellose eye drops  Hydroxychloroquine  Low-dose prednisolone  Steroid sparing - Azathioprine, methotrexate and mycophenolate
307
Management of SLE - maintenance - lupus nephritis?
 Induction phase - prednisolone, cyclophosphamide or hydroxychloroquine  Maintenance – azathioprine/mycophenolate + prednisolone  BP control - ACEi, A-blockers or CCB  Renal replacement therapy if disease progresses
308
Management of SLE - maintenance - B-cell depletion?
 Belimumab if autoantibody positive SLE
309
Prognosis of SLE?
o 5-year survival 95%
310
Complications of SLE?
``` o Anaemia o Leucopenia o Thrombocytopenia o Steroid-related problems o Amenorrhoea or infertility due to cyclophosphamide o Pericarditis o Myocarditis o Endocarditis o Pleuritis o Pleural Effusion ```
311
Description of systemic sclerosis?
- Systemic sclerosis is multisystem autoimmune disease where there is increased fibroblast activity resulting in abnormal growth of connective tissue o Causes vascular damage and fibrosis in skin, GI, heart, lungs, other organs o Vascular manifestations unclude secondary Raynaud’s phenomenon, ischaemia of extremities, pulmonary arterial hypertension and renal disease
312
Description of scleroderma?
o Scleroderma refers to dermatological component of systemic sclerosis o Localised scleroderma called morphoea – excessive collagen deposition leading to thickening of dermis
313
Symptoms of scleroderma?
 Plaques thickened, usually oval patches  Mauve colour then change to ivory white in middles with lilac edges  Surface is smooth and shiny
314
Investigations of scleroderma?
 Deep punch biopsy
315
Management of scleroderma?
 UVB phototherapy  UVA phototherapy  Methotrexate +/- prednisolone  Topical tacrolimus, imiquimod
316
Peak age for systemic sclerosis?
40-50
317
Risk factors of systemic sclerosis?
o FHx o CMV, parvovirus B19, HepB, EBV, Toxoplasma, H.pylori, chlamydia o Pesticides, hair dye, silica o Cocaine, bleomycin, penicillamine, vitamin K o Vitamin D deficiency
318
Types of systemic sclerosis?
o Limited cutaneous systemic sclerosis  Areas of skin affected include only face, hands and feet  Older term is CREST (calcinosis, Raynaud’s, oesophageal and gut dysmotility, sclerodactyly and telangiectasia)  Associated with anticentromere antibodies o Diffuse cutaneous systemic sclerosis  Whole body and early organ fibrosis (lung, GI, cardiac and renal)  Antitopoisomerase-1 & anti-RNA polymerase antibodies
319
Symptoms of systemic sclerosis - the two types?
- LcSSc o Milder disease, slow onset and slow progression - DcSSc o Rapid onset, skin thickening and Raynaud’s phenomenon occurring together and skin changes spread rapidly o Symptoms worse in first 3-5 years
320
General features of systemic sclerosis?
o Fatigue | o Weight Loss
321
Skin features of systemic sclerosis?
``` o Swelling of fingers and toes – sclerodactyly o Skin hard and thickened o Raynaud’s phenomenon o Calcinosis – nodules or lumps of chalky material o Tight facial skin and tight lips o Telangiectasia o Salt and Pepper appearance of skin o Dry skin ```
322
MSK features of systemic sclerosis?
o Joint pain and swelling o Myalgia o Restricted joint movements
323
GI features of systemic sclerosis?
``` o GORD o Oesophageal scarring o Fullness after meals o Reduced bowel motility o Constipation ```
324
Pulmonary features of systemic sclerosis?
``` o Fibrosis (ILD) – exertional SOB, cough and crackles o Pulmonary arterial hypertension – exertional SOB, syncope, RV strain ```
325
Cardiac features of systemic sclerosis?
``` o Microvascular CAD o Myocardial fibrosis o LV failure o Pericarditis o Arrhythmias ```
326
Renal features of systemic sclerosis?
o Glomerulonephritis | o Reduced renal function
327
GU features of systemic sclerosis?
o Erectile dysfunction | o Dysparenunia
328
Investigations done in systemic sclerosis?
``` - Bloods o FBC o ESR and CRP o U&E - Antibodies o Anti-topoisomerase 1 (anti-Scl 70) o Anti-centromere antibody (ACA) o Anti-RNA polymerase 3 antibody - Urine protein ```
329
Management of acute systemic sclerosis?
Scleroderma Renal Crisis  BP control – ACEi or CCB  Renal dialysis or transplant
330
Chronic management of systemic sclerosis - non-pharmacological?
```  Physiotherapy  Exercise  Stop smoking  Emollients for skin dryness  Maintain healthy weight ```
331
Chronic management of systemic sclerosis - Pharmacological?
 Methotrexate, mycophenolate or cyclophosphamide
332
Chronic management of systemic sclerosis - Raynaud's Phenomenon?
 Avoid cold weather, stop smoking  CCB (nifedipine)  Aspirin  If ulcers – PDE-5 inhibitors
333
Chronic management of systemic sclerosis - skin?
 Topical emollient  Topical/Oral prednisolone  Antihistamine  If thickening - Methotrexate, mycophenolate or cyclophosphamide
334
Chronic management of systemic sclerosis - GI involvement?
 GORD – PPI |  Gastroparesis – Prokinetic agents (erythromycin, domperidone)
335
Chronic management of systemic sclerosis - ILD?
 Prednisolone  Azathioprine  Continuous Oxygen therapy  Lung transplant
336
Chronic management of systemic sclerosis - pulmonary arterial hypertension?
 PDE-5 inhibitor  Oxygen  Lung transplant
337
Monitoring in systemic sclerosis?
o Annual LFTs, Echos | o Monitor U&Es and BP closely
338
Description of rotator cuff disorders?
o Subacromial pain which is felt in top and lateral side of shoulder o Most common cause of shoulder pain, typically 35-75 and history of repetitive movements at shoulder height or heavy lifting o Include:  Tendinopathy • Shoulder impingement – between acromion and rotator cuff tendons  Partial rotator cuff tears
339
Diagnosis of rotator cuff injury?
 Pain in top and lateral side of shoulder made worse by lifting arm or overhead activities  Night pain  Painful and restricted active movements  Painful passive movements  Painful arc syndrome – 70-120o of abduction
340
Description of frozen shoulder?
o Stiffness and disability of shoulder o Progressive restriction of both active and passive shoulder movement o Typically 40-60, women o Primary or secondary (trauma, rotator cuff tear, CVD, hemiparesis, diabetes, thyroid disease)
341
Phases of frozen shoulder?
 Painful phase – lasts 2-9 months, pain on movement, severe and can disturb sleep  Stiffness phase – lasts 4-12 months, less severe and reduced ROM  Resolution phase – lases 12-42 months, improvement gradually
342
Diagnosis of frozen shoulder?
 Gradual onset pain in deltoid region, worsening shoulder stiffness  Restricted active and passive external rotation
343
Description of shoulder instability?
o Abnormal movement of head of humerus o Typically, <35 years, shoulder feeling out of joint or moves o Causes pain, subluxation or dislocation
344
Diagnosis of shoulder instability?
 Shoulder moves partly or feeling out of joint  Ache or clicking  Arm weakness, tingling  Shoulder dislocation • Anterior – fall onto outstretched hand, <20 years have 90% of further dislocation • Posterior
345
When to XR shoulder?
- Anteroposterior and lateral shoulder XR: o History of trauma o Person not improving with conservative treatments o Movement restricted o Severe pain o Arthritis suspected
346
Management of shoulder pain - when to refer urgently?
```  Trauma, pain and weakness, or sudden loss of ability to actively raise the arm  Any shoulder mass or swelling  Red skin, painful joint, fever  Trauma leading to abnormal shape  New inflammatory symptoms  Systemic symptoms  Acute rotator cuff tear ```
347
Management of shoulder pain - initial management?
```  Analgesia • Paracetamol 1st line • Oral NSAIDs or codeine added on  Encourage carrying out normal daily activities if they are able  Refer to physiotherapy ```
348
Management of shoulder pain - when to refer to secondary care?
 Recurrent shoudler instability  Post-traumatic pain  Not improving after 3 months
349
Management of rotator cuff disorders - general management?
o Rest in acute phase – avoid reaching overhead o Resume normal activities when feel able to do so o Analgesia  Paracetamol 1st line  Oral NSAIDs or codeine added on o Exercises/Physio (6 weeks) o Corticosteroid injection  Give another after 6 weeks if improvement
350
Management of rotator cuff disorders - referral?
 Not benefitted after 6 weeks of non-surgical treatment
351
Management of rotator cuff disorders - surgery?
 Arthroscopic rotator cuff tendon repair if large
352
Management of frozen shoulder?
``` o Avoid movements that worsen pain but continue to use to avoid stiffness o Heat packs o In bed, support arm with pillow o Analgesia • Paracetamol 1st line • Oral NSAIDs or codeine added on o Physiotherapy (6 weeks) o Referral to secondary care:  Pain or stiffness for 3 months and not benefitting from conservative measures ```
353
Description of lateral epicondylitis (Tennis Elbow)?
- Tendonosis affects attachment of tendons of extensor muscles of forearm to lateral epicondyle of humerus
354
Epidemiology of lateral epicondylitis (Tennis Elbow)?
- Prevalence of 1-3%, peak 35-55 years - Most commonly affected muscle is extensor carpi radialis brevis - Dominant arms in 75%
355
Causes of lateral epicondylitis (Tennis Elbow)?
o Minor trauma – repetitive overuse causes micro-tears near origin of common extensor tendon which initiates degenerative process
356
Activities associated of lateral epicondylitis (Tennis Elbow)?
o Tennis o Plumbing o Grip-tensive activities involving repetitive forceful elbow movements
357
Symptoms of lateral epicondylitis (Tennis Elbow)?
- Pain in lateral elbow, with wrist extension and reduced grip strength o Radiates down extensor aspect of forearm o Worsened by excessive and repetitive use of extensor muscles of forearm (strong gripping, repetitive wrist movements) o Occupations using vibratory machines worsen symptoms - Impacts on ADLs
358
What is Mill's Test?
o Straighten patients arm and palpate lateral epicondyle o Fully flex wrist o Pronate patients’ forearm o If painful – positive test
359
What is Cozen's Test?
o Elbow 90 degree of flexion, patient makes a fist and deviates wrist radially with forearm pronated o Resisted extension of wrist o Pain in lateral epicondyle is positive result
360
General management of lateral epicondylitis (Tennis Elbow)?
o Avoid heavy lifting, forceful gripping or twisting actions that may aggravate it o Discuss with OH if work-related  May mix work patterns, take more rest breaks, change handling procedures
361
Further management of lateral epicondylitis (Tennis Elbow)?
- Analgesia o Paracetamol and Ibuprofen gel 1st line o Oral if symptoms ongoing o Corticosteroid injection (may be repeated 2-3 times at 3-6 months intervals) - Physiotherapy
362
When to refer to orthopaedics in lateral epicondylitis (Tennis Elbow)?
o Uncertain diagnosis o Refractory pain o Pain >12 months despite optimal treatment
363
Prognosis of lateral epicondylitis (Tennis Elbow)?
Self-limiting and improves in about 80% of cases over 1-2 years
364
Description of medial epicondylitis (Golfer's elbow)?
- Tendonosis of flexor forearm muscles which insert into medial epicondyle, causing medial elbow pain
365
Causes of medial epicondylitis (Golfer's elbow)?
``` o Golf and other sports o DIY o Computer use o Climbing o Use of vibrating tools ```
366
Symptoms of medial epicondylitis (Golfer's elbow)?
- Pain and tenderness over medial epicondyle, radiating into forearm o Aggravated by wrist flexion and pronation o Gradual onset
367
Tests done in medial epicondylitis (Golfer's elbow)?
- Golfer’s elbow test o Pronate and flex wrist and forearm at same time o Pain over medial epicondyle is positive test
368
General measures of medial epicondylitis (Golfer's elbow)?
o Avoid heavy lifting, forceful gripping or twisting actions that may aggravate it o Discuss with OH if work-related  May mix work patterns, take more rest breaks, change handling procedures
369
Further management of medial epicondylitis (Golfer's elbow)?
- Analgesia o Paracetamol and Ibuprofen gel 1st line o Oral if symptoms ongoing o Corticosteroid injection (may be repeated 2-3 times at 3-6 months intervals) - Physiotherapy
370
Referral to orthopaedics in medial epicondylitis (Golfer's elbow)?
o Uncertain diagnosis o Refractory pain o Pain >12 months despite optimal treatment